Stem Holdings, Inc. (STMH)
OTCMKTS: STMH · Delayed Price · USD
0.0200
0.00 (0.00%)
Apr 25, 2024, 3:33 PM EDT - Market closed
Stem Holdings Revenue
Stem Holdings had revenue of $15.83M in the twelve months ending June 30, 2023, down -27.10% year-over-year. Revenue in the quarter ending June 30, 2023 was $3.83M, a -8.18% decrease year-over-year. In the fiscal year ending September 30, 2022, Stem Holdings had annual revenue of $16.56M, a decrease of -53.69%.
Revenue (ttm)
$15.83M
Revenue Growth
-27.10%
P/S Ratio
0.01
Revenue / Employee
$105,527
Employees
150
Market Cap
113.00K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2022 | 16.56M | -19.21M | -53.69% |
Sep 30, 2021 | 35.77M | 21.80M | 155.97% |
Sep 30, 2020 | 13.97M | 11.52M | 470.13% |
Sep 30, 2019 | 2.45M | 1.16M | 89.17% |
Sep 30, 2018 | 1.30M | 969.65K | 297.40% |
Sep 30, 2017 | 326.04K | - | - |
Sep 30, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
STMH News
- 2 months ago - CSE Bulletin: Suspension - Stem Holdings Inc. (STEM) - Newsfile Corp
- 2 months ago - CSE Bulletin: Consolidation - Stem Holdings Inc. (STEM) - Newsfile Corp
- 2 months ago - Stem Holdings, Inc. Announces Clarification Regarding Effective Date of Reverse Share Split on the Canadian Securities Exchange - GlobeNewsWire
- 3 months ago - Stem Holdings, Inc. Announces Effectiveness of Reverse Stock Split on February 1, 2024. - GlobeNewsWire
- 3 months ago - Stem Holdings Announces Delay in Annual Filings and Expected Cease Trade Order - GlobeNewsWire
- 5 months ago - Stem Holdings Announces Approval of Debenture Repricing - GlobeNewsWire
- 1 year ago - Stem Holdings, Inc and Headwaters, LLC Sign Term Sheet for a Business Combination - GlobeNewsWire
- 1 year ago - Stem Holdings Announces Closing of Note Offering - GlobeNewsWire